Sacituzumab govitecan

Classification

1. Anatomical main groupLAntineoplastic and immunomodulating agents
2. Therapeutic subgroupL01Antineoplastic agents
3. Pharmacological subgroupL01F
4. Chemical subgroupL01FXOther monoclonal antibodies and antibody drug conjugates
5. Chemical substanceL01FX17Sacituzumab govitecan

Where it is registered

Each register with its number of medicines and a few of them.

• 🇪🇸Spain

  AEMPS · 2 medicines

  • Trodelvy 200 MG Polvo Para Concentrado Para Solucion Para Perfusion200 mg · polvo para concentrado para solución para perfusión · Gilead Sciences Ireland Unlimited Company
  • Trodelvy 200 MG Polvo Para Concentrado Para Solucion Para Perfusion200 mg · polvo para concentrado para solución para perfusión · Gilead Sciences Ireland Unlimited Company

• 🇧🇷Brazil

  Anvisa · 1 medicine

  • TrodelvyGilead Sciences Farmaceutica do Brasil Ltda